Migraine: open trials in Hungary

• NCT06810505

  A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  Trial Treatment · Phase 3 · AbbVie

  Semmelweis University, Budapest · CEBA Egeszseguegyi Bt., Budapest XIV

  Registry updated 2026-10-09

• NCT05711394

  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  Trial Treatment · Phase 3 · AbbVie

  S-Medicon Kft., Budapest · Semmelweis University, Budapest · MIND Klinika Kft., Budapest II · Clinexpert Kft., Budapest III · Semmelweis University, Budapest VIII · Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaza, Budapest Xiv

  Registry updated 2026-10-06

• NCT05707949

  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  Trial Treatment · Phase 3 · AbbVie

  S-Medicon Kft., Budapest · Semmelweis University, Budapest · MIND Klinika Kft., Budapest II · Clinexpert Kft., Budapest III · Semmelweis University, Budapest VIII · Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaza, Budapest Xiv

  Registry updated 2025-08-11

All Migraine trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error